Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma.

Trial Profile

Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jan 2009

At a glance

  • Drugs Budesonide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jan 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 22 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top